Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/2005
06/01/2005EP1535617A1 Remedy or preventive for keratoconjunctival epithelial cell injury
06/01/2005EP1535609A1 Nf-kb activation inhibitors
06/01/2005EP1534847A1 Retroviral vector and stable packaging cell lines
06/01/2005EP1534807A1 A process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid
06/01/2005EP1534753A2 Antibody peg positional isomers, compositions comprising same, and use thereof
06/01/2005EP1534725A2 Compounds and methods for inhibiting selectin-mediated function
06/01/2005EP1534720A1 Mitochondrially targeted antioxidants
06/01/2005EP1534706A1 Furanthiazole derivatives as heparanase inhibitors
06/01/2005EP1534687A1 Pyrimidine compounds
06/01/2005EP1534686A2 Nf-kb inhibitors and uses thereof
06/01/2005EP1534681A1 Substituted quinoline ccr5 receptor antagonists
06/01/2005EP1534677A1 Piperidine derivatives and their use as selective inhibitors of mip-1alpha binding to its receptor ccr1
06/01/2005EP1534676A1 Piperidinetriol derivatives as inhibitors of glycosylceramide synthase
06/01/2005EP1534668A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
06/01/2005EP1534666A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex
06/01/2005EP1534512A1 Coated particles, methods of making and using
06/01/2005EP1534368A1 Medicament dispenser
06/01/2005EP1534332A2 Antibodies and uses thereof
06/01/2005EP1534304A1 An analgesic agent for newborn or fetal subjects
06/01/2005EP1534300A2 3, 10, and 12a substituted tetracycline compounds
06/01/2005EP1534293A1 Anti-inflammatory compositions and methods of use
06/01/2005EP1534290A2 Novel inhibitors of kinases
06/01/2005EP1534289A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders
06/01/2005EP1534278A2 Nitrosated proton pump inhibitors, compositions and methods of use
06/01/2005EP1534274A1 Combination of an allosteric alkyne inhibitor of matrix metalloproteinase-13 with celecoxib or valdecoxib
06/01/2005EP1534260A2 Perfluorinated fatty acids for the treatment of obesity, diabetes, hyperlipidaemia, cancer and inflammation
06/01/2005EP1534256A2 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
06/01/2005EP1534250A2 Electrospun amorphous pharmaceutical compositions
06/01/2005EP1534241A1 Transdermal aerosol compositions
06/01/2005EP1453820B1 Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents
06/01/2005EP1404330B1 Substituted 8-arylquinoline pde4 inhibitors
06/01/2005EP1253904B1 Use of extracts from residues left in the production of wine as cosmetic care actives for skin and hair
06/01/2005EP1233951B1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
06/01/2005EP1218064B1 COMPOSITIONS FOR TREATING AUTOIMMUNE DISEASEs CONTAINING A COMPOUND WHICH INHIBITS ICAM-LFA-1 INTERACTION AND A COMPOUND WHICH INHIBITS CD40-CD40 LIGAND INTERACTION
06/01/2005EP1188754B1 Substituted pyrazole compounds
06/01/2005EP1178977B1 Ion channel modulating agents
06/01/2005EP1062210B1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors
06/01/2005CN1622995A Receptor nucleic acids and polypeptides
06/01/2005CN1622946A Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
06/01/2005CN1622830A Peptide-based compounds
06/01/2005CN1622819A An anti-rheumatism medicament and preparation method thereof
06/01/2005CN1622812A Prophylactic and therapeutic treatment of infectious and other diseases with immune effect compound
06/01/2005CN1622796A Topical anti-inflammatory compositions and methods of reducing inflammation
06/01/2005CN1621526A Recombinant adeno-associated virus for prevention and cure of I-type diabetes and use thereof
06/01/2005CN1621069A Health caring medicinal liquor for eliminating pain
06/01/2005CN1621064A Chinese medicine for treating wind-warm disease
06/01/2005CN1621041A Pharmaceutical composition with pain easing function
06/01/2005CN1621035A Injection of flurbiprofen and its preparing method
06/01/2005CN1621034A Freeze dry powder injection of ketoprofen
06/01/2005CN1203899C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy
06/01/2005CN1203887C Traditional Chinese medicine for treating arthralgia and preparation process thereof
06/01/2005CN1203884C Medicament for treating rheumatism
06/01/2005CN1203879C Medicine for treating rheumatoid and rheumatic diseases
06/01/2005CN1203860C Application of Na-ion channel blocker and aspirin in preparing antalgic medicine for mammal
06/01/2005CN1203857C Method for localized anesthesia and analgesia
06/01/2005CN1203852C Valdecoxib compositions
06/01/2005CN1203851C Use of inhibitor produced or released by reactive oxygen metablite in producing pharmaceutical
06/01/2005CN1203849C Remedy for keratoconjunctival diseases
06/01/2005CN1203848C P-ethyl phenol aminophenol anal injection for children and its preparationn method
06/01/2005CN1203845C Pharmaceutical composition comprising profen
05/2005
05/31/2005US6900336 8-aza-11-deoxy prostaglandin analogues
05/31/2005US6900334 Antiallergens; autoimmune diseases
05/31/2005US6900318 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor
05/31/2005US6900311 O-sulphated bacterial polysaccharides and their use
05/31/2005US6900309 Aminocarbonylation reaction of a adenosine compound containing purine base and pentofuranosyl sugar and a leaving group at 2 position of purine ring, with an amine compound in presence of carbon monoxide and suitable coupling catalyst
05/31/2005US6900243 Phenylheteroalkylamine derivatives
05/31/2005US6900242 Compound for use in the treatment of cancer and prevention of infections
05/31/2005US6900231 Aminopyridyl-substituted phenyl acetamides as protease inhibitors
05/31/2005US6900230 Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents
05/31/2005US6900214 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
05/31/2005US6900212 Anxiolytic agents; psychological disorders; sexual disorders; eating disorders
05/31/2005US6900211 CCR5 antagonists useful for treating aids
05/31/2005US6900202 Nicotinic acetylcholine receptor activators; treating neurodegenerative disorders
05/31/2005US6900201 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
05/31/2005US6900194 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
05/31/2005US6900043 Phosphatases which activate map kinase pathways
05/31/2005US6900041 Adding compound suspected of effecting glycogen synthase kinase 3 beta (GSK-3 beta ) to cells; adding an inflammatory molecule; measuring determinant of GSK- 3 beta
05/31/2005US6899897 Comprises benzoin gum, fungicidal clotrimazole, and ethanol; for treatment of athelete's foot, eczema, seborrheic dermatitis and psoriasis
05/31/2005US6899893 Method for treating an allergic or inflammatory disease
05/31/2005US6899879 Method for treating an IgE-mediated disease in a patient using anti-CD40 monoclonal antibodies
05/31/2005US6899867 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
05/31/2005US6899723 Transcutaneous photodynamic treatment of targeted cells
05/26/2005WO2005046569A2 Pharmaceutical compositions for the treatment of sars
05/26/2005WO2005027951B1 Method for controlling angiogenesis in animals
05/26/2005WO2004104015A8 Mannose-6-phosphonate compounds for the treatment of inflammatory diseases
05/26/2005US20050113577 Such as hydrochloride salt 3-[5-(4-methanesulfonyl-piperazin-1-yl-methyl)-1H-indol-2-yl]-1H-quinolin-2-one; signal transduction; for treatment of angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, and inflammatory diseases
05/26/2005US20050113451 7-acetamidinyl derivatives
05/26/2005US20050113430 2-[o-(aminoalkoxy)phenyl])-3-acylbenzothiazolines, e.g., 3-Acetyl-6-chloro-2-[2-(3-(N-(2-hydroxyethyl)-N-isopropylamino)-propoxy)-5-methoxyphenyl]benzothiazoline; treating pruritus or pain, particularly that caused by a rheumatic disease
05/26/2005US20050113426 Polyhydroxylated benzene-containing compounds
05/26/2005US20050113416 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
05/26/2005US20050113414 1-[1-((E)-1-Cyclooct-1-enyl)methylpiperidin-4-yl]-3-(3,4-dichlorophenyl)-urea; potent and selective modulators of CXCR3, a chemokine receptor; antagonists; treatment of conditions involving inappropriate T-cell trafficking; antiinflammatory, -arthritic agents, autoimmune diseases; antiallergens
05/26/2005US20050113386 Treating bipolar disorder, mania, dementia, sexual dysfunction, eating disorders, fibromyalgia
05/26/2005US20050113377 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase, 2 (COX-2) inhibitors
05/26/2005US20050113370 Therapeutic substituted indazole derivatives
05/26/2005US20050113368 eg (+-) Ethyl 3-[4-{3-(3,4-dihydro-2H-benzo[b][1,4]oxazin-4-yl)propylamino}phenyl]-2-ethoxypropanoate; antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic
05/26/2005US20050113361 Amide derivatives as NMDA receptor antagonists
05/26/2005US20050113360 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one
05/26/2005US20050113359 NMDA (N-methyl-D-aspartate) receptors; eg 1-[4-(4-fluoro-benzyl)-piperidin-1-yl]-1-(6-hydroxy-1H-indole-2-yl)methanone
05/26/2005US20050113299 Protein a compositions and methods of use
05/26/2005US20050113291 Use of a substance which binds to and initiates signaling of the human SARP-1 receptor or a substance which stimulates release or potentiates the activity of endogenous SARP-1 for the manufacture of a medicament for the treatment and/or prevention of scleroderma, in particular of systemic sclerosis
1 ... 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 ... 1272